glp-1 mimetics Agonist Effects on Glucagon Suppression Frontiers | GLP-1 Receptor Agonists:

Wegovy Pill (Oral Semaglutide 25 mg Daily) According to the FDA approval announcement dated December 22, 2025, the Wegovy pill is indicated for the same population as the injection formulation

For women planning pregnancy or in early pregnancy : folic acid (400 micrograms daily) is essential to reduce the risk of neural tube defects

Although this review primarily focuses on transdermal applications, MN technologies are also being explored for non-transdermal routes, including ocular, buccal, and mucosal delivery

Zepbound (Tirzepatide): Offering exceptional weight loss outcomes, this injectable targets multiple appetite pathways